肾移植后复发性肾小球肾炎:危险因素与移植物结局
基于ANZDATA登记系统30年数据,纳入6597例以活检证实的肾小球肾炎为原发病的肾移植受者,随访51871人年。四种常见肾小球肾炎中479/4637例复发,其中212例因复发失去移植物。移植时年龄较大与复发风险降低相关,复发性MPGN的5年移植物存活率仅30%,复发者移植物丢失风险为无复发者的2.04倍。
要点
- 肾移植后复发性肾小球肾炎显著增加移植物丢失风险(aHR 2.04)。
- 复发性MPGN的5年移植物存活率最低,仅30%。
- 移植时年龄每增加1岁,复发风险降低4%(aHR 0.96)。
核心结论
- 复发性肾小球肾炎仍是肾移植受者移植物丢失的重要原因。
研究设计与样本
- 基于澳大利亚和新西兰透析与移植登记系统30年数据的回顾性队列研究,纳入6597例以活检证实的肾小球肾炎为终末期肾病原发病的肾移植受者,随访51871人年(中位7.7年)。
主要发现
- 四种常见肾小球肾炎(IgA肾病2501例、FSGS 1403例、膜性肾病376例、MPGN 357例)中,479/4637例报告复发,其中212例因复发失去移植物。
- 移植时年龄较大与复发风险降低相关(每增加1岁,aHR 0.96,95%CI 0.95-0.97)。
- 复发性MPGN的5年移植物存活率为30%,复发性FSGS、IgA肾病和膜性肾病为57-59%。
- 复发者移植物丢失风险为无复发者的2.04倍(95%CI 1.81-2.31)。
临床怎么用
- 对肾移植受者应警惕复发性肾小球肾炎,尤其MPGN和FSGS等类型,需加强监测以降低移植物丢失风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Recurrent glomerulonephritis after kidney transplantation is a feared complication because it is unpredictable and may have a negative impact on graft outcomes. To better understand this we collected data from the Australia and New Zealand Dialysis and Transplant (ANZDATA) Registry accumulated over 30 years. The incidence, risk factors, and outcomes of recurrent glomerulonephritis in transplant recipients were determined using adjusted Cox proportional hazard and competing risk modeling. A total of 6,597 recipients with biopsy-proven glomerulonephritis as the primary cause of end-stage kidney disease were followed for 51,871 person-years (median duration 7.7 years). The four most common types of glomerulonephritis were IgA nephropathy in 2501 patients, focal segmental glomerulosclerosis (FSGS) in 1403, membranous in 376, and membranoproliferative (MPGN) nephropathy in 357 patients. Among these four types, recurrence was reported in 479 of 4637 patients, and of these, 212 lost their allograft due to recurrence. Older age at transplantation (adjusted hazard ratio [per year increase] 0.96 [95% confidence interval 0.95 - 0.97]) was associated with a lower risk of recurrence. Significantly, the five-year graft survival was 30% for recipients with recurrent MPGN and 57-59% for recipients with FSGS, IgA, and membranous nephropathy. Transplant recipients with recurrent disease were twice as likely to lose their allografts compared to those without recurrence (adjusted hazard ratio 2.04 [1.81-2.31]). Thus, recurrent glomerulonephritis remains a significant cause of graft loss in transplant recipients.
引用
- Allen PJ, Chadban SJ, Craig JC, et al. Recurrent glomerulonephritis after kidney transplantation: risk factors and allograft outcomes. Kidney Int. 2017. PMID: 28601198. doi:10.1016/j.kint.2017.03.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。